7 results match your criteria: "University of Pennsylvania (J.D.)[Affiliation]"
Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic: Experience From an Autoimmune Neurology Center.
Neurol Neuroimmunol Neuroinflamm
July 2023
From the Consorci Institut D'Investigacions Biomediques August Pi i Sunyer (H.A., R.R.G., E.M.-H., A.S., F.G., J.D.); Neurology Service, Hospital Clínic de Barcelona (R.R.G., L.N., E.M.-H., A.S., J.D.); University of Barcelona (A.S., J.D.); Hospital Universitario Central de Asturias (B.R.), Oviedo; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid; Catalan Institution for Research and Advanced Studies (J.D.) Barcelona, Spain; and Department of Neurology, University of Pennsylvania (J.D.), Philadelphia, PA.
Objective: To determine whether the frequency of paraneoplastic or autoimmune encephalitis antibodies examined in a referral center changed during the COVID-19 pandemic.
Methods: The number of patients who tested positive for neuronal or glial (neural) antibodies during pre-COVID-19 (2017-2019) and COVID-19 (2020-2021) periods was compared. The techniques used for antibody testing did not change during these periods and included a comprehensive evaluation of cell-surface and intracellular neural antibodies.
year in review.
Neurol Neuroimmunol Neuroinflamm
January 2020
From the ICREA-IDIBAPS Hospital Clínic, University of Barcelona (J.D.), Spain; University of Pennsylvania (J.D., D.L.K.), Philadelphia; University of Athens Medical School (M.C.D.), Athens, Greece; Jefferson University (M.C.D.), Philadelphia, PA; Charite University Hospital (F.P.), Berlin, Germany; and Department of Neurology (S.S.Z.), University of California, San Francisco.
N2 year in review and message from the editor to our reviewers.
Neurol Neuroimmunol Neuroinflamm
January 2019
ICREA-IDIBAPS, Hospital Clínic (J.D.), University of Barcelona, Spain; the University of Pennsylvania (J.D, D.L.K.), Philadelphia, PA; the Charite University Hospital (F.P.), Berlin, Germany; and the Department of Neurology (S.S.Z.), University of California, San Francisco, CA.
The clinical spectrum of Caspr2 antibody-associated disease.
Neurology
August 2016
From the Departments of Neurology (A.v.S., P.A.E.S.S., M.J.T.) and Immunology (M.W.J.S.), Erasmus University Medical Center, Rotterdam; Department of Neurology (A.v.S., P.W.W.), Haga Teaching Hospital, the Hague, the Netherlands; Department of Neurology (H.A., F.G.), Hospital Clinic, University of Barcelona; Neuroimmunology Program (H.A., M.P.-P., F.G.) and Department of Neurology, Hospital Clinic (J.D.), Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Neuroimmunology (F.L.), Institute of Clinical Chemistry, Christian-Albrechts-University; Department of Neurology (F.L.), University Hospital Schleswig-Holstein, Kiel; Department of Neurology (P.K.), University Hospital Magdeburg; Neuroimmunology (K.-P.W), Institute of Clinical Chemistry, University Medical Center Schleswig-Holstein Campus Lübeck; Department of Neurology (K.-P.W), University of Lübeck, Germany; Department of Neurology (E.L.), University of Pennsylvania (J.D.), Philadelphia; and Department of Neurology (J.D.), Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Objective: To report a large cohort of patients with antibodies against contactin-associated protein-like 2 (Caspr2) and provide the clinical spectrum of this disorder.
Methods: Serum and CSF samples were assessed at 2 neuroimmunology centers in Barcelona and Rotterdam. Patients were included if Caspr2 antibodies were confirmed with 2 independent techniques, including brain immunohistochemistry and cell-based assay.
Orthostatic myoclonus associated with Caspr2 antibodies.
Neurology
April 2016
From Christian-Albrecht University of Kiel (F.G., K.W., H.H., S.P., G.D., F.L.), Germany; University College London (UCL) Institute of Neurology (R.E.), UK; August Pi i Sunyer Biomedical Research Institute (IDIBAPS) (E.M.-H., J.D.), Hospital Clínic, University of Barcelona, Spain; Institute of Clinical Chemistry (K.P.-W.), University of Lübeck (K.P.-W.), Germany; University of Pennsylvania (J.D.), Philadelphia; Catalan Institution for Research and Advanced Studies (ICREA) (J.D.), Barcelona, Spain; and Neuroimmunology (F.L.), Institute of Clinical Chemistry, Christian-Albrecht University of Kiel, Germany.
When a serum test overrides the clinical assessment.
Neurology
March 2015
From the Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS) (T.A., J.D.), Hospital Clínic (J.S.), University of Barcelona; Institució Catalana de Recerca i Estudis Avançats (ICREA) (J.D.), Barcelona, Spain; and the University of Pennsylvania (J.D.), Philadelphia.
Neuropathologic features of anti-dipeptidyl-peptidase-like protein-6 antibody encephalitis.
Neurology
January 2015
From Psychiatric University Hospital (G.B.S., A.K.), Ljubljana; University Medical Centre (G.B.S.), Ljubljana; University of Ljubljana (M.P., A.K.), Slovenia; Neurological Tissue Bank of the Biobanc-Hospital Clinic-IDIBAPS (E.G.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (E.G., J.D., F.G.), Barcelona, Spain; University of Pennsylvania (J.D.), Philadelphia; Institució Catalana de Recerca i Estudis Avançats (ICREA) (J.D.); and Universitat de Barcelona (F.G.), Barcelona, Spain.